X-79361416-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_004867.5(ITM2A):c.616C>T(p.Arg206Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000382 in 1,204,557 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004867.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITM2A | ENST00000373298.7 | c.616C>T | p.Arg206Cys | missense_variant | Exon 5 of 6 | 1 | NM_004867.5 | ENSP00000362395.2 | ||
ITM2A | ENST00000434584.2 | c.484C>T | p.Arg162Cys | missense_variant | Exon 4 of 5 | 2 | ENSP00000415533.2 | |||
ITM2A | ENST00000469541.5 | n.576C>T | non_coding_transcript_exon_variant | Exon 5 of 6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000445 AC: 5AN: 112330Hom.: 0 Cov.: 24 AF XY: 0.0000580 AC XY: 2AN XY: 34508
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 182561Hom.: 0 AF XY: 0.0000298 AC XY: 2AN XY: 67153
GnomAD4 exome AF: 0.0000375 AC: 41AN: 1092227Hom.: 0 Cov.: 28 AF XY: 0.0000475 AC XY: 17AN XY: 357901
GnomAD4 genome AF: 0.0000445 AC: 5AN: 112330Hom.: 0 Cov.: 24 AF XY: 0.0000580 AC XY: 2AN XY: 34508
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.616C>T (p.R206C) alteration is located in exon 5 (coding exon 5) of the ITM2A gene. This alteration results from a C to T substitution at nucleotide position 616, causing the arginine (R) at amino acid position 206 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at